Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001706:Biopsy; D001782:Blood Donors; D002908:Chronic Disease; D003718:Denmark; D000939:Epitopes; D005500:Follow-Up Studies; D006306:Health Surveys; D006505:Hepatitis / Q000097:blood / Q000201:enzymology / Q000276:immunology*; D006506:Hepatitis A / Q000097:blood / Q000201:enzymology / Q000276:immunology / Q000473:pathology; D006511:Hepatitis B Antigens / Q000302:isolation & purification*; D006801:Humans; D007136:Immunoglobulins / Q000302:isolation & purification; D008103:Liver Cirrhosis / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011234:Precipitins / Q000302:isolation & purification; D011516:Prothrombin / Q000032:analysis
D000939:Epitopes; D006511:Hepatitis B Antigens; D007136:Immunoglobulins; D011234:Precipitins; D011516:Prothrombin; D001219:Aspartate Aminotransferases; D001663:Bilirubin